Senior insider sale
ENLIVEN THERAPEUTICS, INC. — senior position signals high conviction
$9.22M
158.79K shares
What this filing means
DERYNCK MIKA K plans to sell 158.79K shares of ENLIVEN THERAPEUTICS, INC. valued at approximately $9.22M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001974158-26-000095
158.79K
Shares to sell
$9.22M
Approx. market value
158.79K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Stock Options
N/A
2/6/2025
20.49KStock Options
N/A
2/13/2024
23.36KStock Options
N/A
2/23/2023
27.57KStock Options
N/A
8/9/2022
87.37KTotal acquired158.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2025 | Stock Options N/A | 20.49K | — |
2/13/2024 | Stock Options N/A | 23.36K | — |
2/23/2023 | Stock Options N/A | 27.57K | — |
8/9/2022 | Stock Options N/A | 87.37K | — |
| Total | 158.79K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
158.79K
Market value
$9.22M
8/4/2026
Total
Units
158.79K
Value
$9.22M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/4/2026 | 158.79K | $9.22M | NASDAQ | Planned |
| Total | 158.79K | $9.22M | ||